Sun Pharmaceutical Industries Ltd — Ciprofloxacin Exporter Profile
Indian Pharmaceutical Exporter · #13 for Ciprofloxacin · $1.0M export value · DGFT Verified
Sun Pharmaceutical Industries Ltd is the #13 Indian exporter of Ciprofloxacin with $1.0M in export value and 20 verified shipments. Sun Pharmaceutical Industries Ltd holds a 0.3% market share in Ciprofloxacin exports across 7 countries.
Sun Pharmaceutical Industries Ltd — Ciprofloxacin Export Profile: Buyers & Destinations
Where Does Sun Pharmaceutical Industries Ltd Export Ciprofloxacin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| RUSSIA | $4.2M | 108 | 36.9% |
| UNITED STATES | $2.3M | 46 | 20.0% |
| BELGIUM | $2.0M | 116 | 17.4% |
| CANADA | $862.0K | 25 | 7.6% |
| FRANCE | $528.3K | 21 | 4.7% |
| AUSTRALIA | $459.3K | 32 | 4.0% |
| UKRAINE | $325.2K | 12 | 2.9% |
| SOUTH AFRICA | $309.4K | 35 | 2.7% |
| GERMANY | $116.0K | 3 | 1.0% |
| ZAMBIA | $66.8K | 9 | 0.6% |
Sun Pharmaceutical Industries Ltd exports Ciprofloxacin to 22 countries. The largest destination is RUSSIA accounting for 36.9% of Sun Pharmaceutical Industries Ltd's Ciprofloxacin shipments, followed by UNITED STATES (20.0%) and BELGIUM (17.4%). These destinations reflect Sun Pharmaceutical Industries Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Ciprofloxacin from Sun Pharmaceutical Industries Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| AO RANBAXY | RUSSIA | $3.0M | 84 |
| YUSEN LOGISTICS BENELUX BELGIUM | BELGIUM | $1.9M | 111 |
| SUN PHARMACEUTICAL INDUSTRIES,INC. | UNITED STATES | $1.3M | 26 |
| AO "RANBAXY" | RUSSIA | $772.7K | 16 |
| SUN PHARMACEUTICAL INDUSTRIES INC | UNITED STATES | $650.0K | 13 |
| TARO PHARMACEUTICALS INC., | CANADA | $402.0K | 9 |
| M S AO RANBAXY | RUSSIA | $400.0K | 8 |
| TARO PHARMACEUTICALS INC | CANADA | $300.0K | 6 |
| SUN PHARMA ANZ PTY LTD. | AUSTRALIA | $291.0K | 20 |
| RANBAXY PHARMACEUTICALS PTY LTD., | SOUTH AFRICA | $182.2K | 22 |
Sun Pharmaceutical Industries Ltd supplies Ciprofloxacin to 60 buyers globally. The largest buyer is AO RANBAXY (RUSSIA), followed by YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM) and SUN PHARMACEUTICAL INDUSTRIES,INC. (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Ciprofloxacin Export Value and How Much Does Sun Pharmaceutical Industries Ltd Contribute?
India exported $74.6M worth of Ciprofloxacin through 14,146 shipments from 1001 suppliers to 180 countries, serving 3,081 buyers globally. Sun Pharmaceutical Industries Ltd contributes $1.0M to this total, accounting for 0.3% of India's Ciprofloxacin exports. Sun Pharmaceutical Industries Ltd ships Ciprofloxacin to 22 countries through 60 buyers.
What Is the Average Shipment Value for Sun Pharmaceutical Industries Ltd's Ciprofloxacin Exports?
Sun Pharmaceutical Industries Ltd's average Ciprofloxacin shipment value is $50.0K per consignment, based on 20 shipments totaling $1.0M. The largest destination is RUSSIA (36.9% of Sun Pharmaceutical Industries Ltd's Ciprofloxacin exports).
How Does Sun Pharmaceutical Industries Ltd Compare to Other Indian Ciprofloxacin Exporters?
Sun Pharmaceutical Industries Ltd ranks #13 among 1001 Indian Ciprofloxacin exporters with a 0.3% market share. The top 3 exporters are SUN PHARMACEUTICAL INDUSTRIES LIMITED ($20.4M), AUROBINDO PHARMA LTD ($11.4M), SENTISS PHARMA PRIVATE LIMITED ($8.8M). Sun Pharmaceutical Industries Ltd processed 20 shipments to 7 destination countries.
What Ciprofloxacin Formulations Does Sun Pharmaceutical Industries Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| CIPROFLOXACIN (0.3%) AND DEXAMETHASONE ( | $550.0K | 11 |
| CIPROFLOXACIN (0.3%) AND DEXAMETHASONE (0.1%) STERILE OTIC SUSPENSION USP,7.5ML- USA (BATCH NO AS PER INVOICE) | $373.4K | 8 |
| CIPROFLOXACIN 0.3% AND DEXAMETHASONE | $250.0K | 5 |
| APO-CIPROFLOXACIN TAB 500mg. EACH FILM C | $174.5K | 7 |
| CIPROFLOXACIN TABLETS 500MG ( CIFRAN TAB | $150.0K | 3 |
| CIFRAN CT TAB PACK:10S STRIP BATCH:DFE8281A, DFE8359A EACH TAB CONTS. CIPROFLOXACIN HCL EQ TO CIPROFLOXACIN 500MG AND TIPCS | $150.0K | 3 |
| CIPROFLOXACIN (0.3%) AND DEXAMETHASONE (0.1%) STERILE OTIC SUSPENSION USP (FOR CANADA) | $150.0K | 3 |
| CIPROFLOXACIN (0.3%) AND DEXAMETHASONE (0.1%) STERILE OTIC SUSPENSION USP,7.5ML- USA PACK : 01*01 (BATCH NO AS PER INVO | $150.0K | 3 |
| CIFRAN CT TAB PACK : 10S STRIP BATCH : DFE8431A, DFE8432A EACH TAB CONTS CIPROFLOXACIN HCL EQ TO CIPROFLOXACIN 500MG ANPCS | $150.0K | 3 |
| CIFRAN CT TAB PACK : 10S STRIP BATCH : DFE8317A, DFE8430A, DFF0019A, DFF0020A EACH TAB CONTS CIPROFLOXACIN HCL EQ TO CIPPCS | $150.0K | 3 |
Sun Pharmaceutical Industries Ltd exports 230 distinct Ciprofloxacin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CIPROFLOXACIN (0.3%) AND DEXAMETHASONE ( with 11 shipments worth $550.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Regulatory Requirements: Exporting Ciprofloxacin to Key Markets
What Sun Pharmaceutical Industries Ltd must comply with to export Ciprofloxacin to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Sun Pharmaceutical Industries Ltd Compare to Nearest Ciprofloxacin Exporters?
Exporters ranked immediately above and below #13 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 10 | MEDNEXT BIOTECH LIMITED | $1.3M | 25 | 4 | $50.0K |
| 3 | DR REDDYS LABORATORIES LIMITED | $1.1M | 22 | 1 | $50.0K |
| 13 | SUN PHARMACEUTICAL INDUSTRIES LTD ★ | $1.0M | 20 | 7 | $50.0K |
| 12 | DR.REDDY'S LABORATORIES LIMITED | $550.0K | 11 | 2 | $50.0K |
Sun Pharmaceutical Industries Ltd ranks #13 among 1001 Indian Ciprofloxacin exporters. Average shipment value of $50.0K compared to the market average of $74.5K. The closest competitors by value are MEDNEXT BIOTECH LIMITED and DR REDDYS LABORATORIES LIMITED.
Which Indian Ports Ship Ciprofloxacin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 1,828 | 12.9% |
| SAHAR AIR | 1,481 | 10.5% |
| NHAVA SHEVA SEA (INNSA1) | 1,254 | 8.9% |
| DELHI AIR CARGO ACC (INDEL4) | 969 | 6.8% |
| JNPT/ NHAVA SHEVA SEA | 766 | 5.4% |
| DELHI AIR | 722 | 5.1% |
| JNPT | 595 | 4.2% |
| Bombay Air | 375 | 2.7% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ciprofloxacin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ciprofloxacin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Sun Pharmaceutical Industries Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 430 individual customs records matching Sun Pharmaceutical Industries Ltd exporting Ciprofloxacin, covering 230 formulations to 22 countries via 60 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 180+ countries, 3,081+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ciprofloxacin Export Data from Sun Pharmaceutical Industries Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Sun Pharmaceutical Industries Ltd's Ciprofloxacin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Sun Pharmaceutical Industries Ltd
Company Profile
0 products · $0 total trade · 0 categories
Ciprofloxacin Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Sun Pharmaceutical Industries Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ciprofloxacin. For current shipment-level data, contact TransData Nexus.